Alamar Biosciences
We're hiring — explore open roles below and apply in a few clicks.
Location
Headquarters: Fremont, California, United States, North America
Region: California
Country: US
Continent: North America
About
Alamar Biosciences is a proteomics company focused on ultra-sensitive, high-mmultiplex protein biomarker detection for plasma and liquid biopsy samples. The company provides NULISA and ARGO HT System-based solutions to accelerate biomarker discovery, validation, and translational research across immunology, neurology, and oncology, with applications spanning academic labs, biopharma, and biotech sectors. Headquartered in Fremont, California, the organization emphasizes precision proteomics to enable early disease detection and personalized medicine.
Alamar Biosciences provides automated, high-throughput proteomics solutions for ultra-sensitive protein analysis in plasma and liquid biopsy samples. Its proprietary NULISA chemistry and ARGO system enable multiplex biomarker detection for immunology, neurology, and oncology research. The company serves academic laboratories, biopharma, and biotech sectors to accelerate biomarker discovery and val
Alamar Biosciences, Inc.
2018
for_profit
active
Industries
Primary Industry: Manufacturing
Categories
Funding & Financials
Grant
260000000
10m-50m
private
NASDAQ:ALMR
NASDAQ
Investors
Founders
Steve Chen
Yiyuan Yin
Yuling Luo
Leadership
Technology Stack
Products
NULISAseq Neuro 220 Panel: A NULISAseq assay panel for detecting neurodegeneration-related protein biomarkers in research.
Funding rounds
IPO · 191300000 · (2026-04-01T00:00:00)
GRANT · 10000000 · (2025-01-01T00:00:00)
SERIES_C · 128000000 · (2024-02-01T00:00:00)
SERIES_B · 80000000 · (2021-09-01T00:00:00)
SERIES_A · 14000000 · (2020-05-01T00:00:00)
